Decision of the Complaints Committee – 00798-21 Reynolds v The Daily Telegraph
Summary of Complaint
1. Peter Reynolds complained to the
Independent Press Standards Organisation that The Daily Telegraph breached Clause
1 (Accuracy) of the Editors’ Code of Practice in an article headlined “'Super
skunk' cannabis led to surge in mental health crises”, published on 29 January
2021.
2. The article, which was based on data
released by NHS Digital, reported that “’Super skunk’ cannabis has contributed
to a record 100,000 people admitted for NHS treatment for drug-related mental
health or behavioural disorders.” The article included quotations from two
experts: a professor of psychopharmacology and a consultant addiction
psychiatrist. One of the experts was described as saying that “over the Covid
pandemic the use of nightclub drugs such as ecstasy had declined while there
had been an increase in cannabis and ketamine, both of which are more
addictive”. The other expert was described as commenting that “fewer people
were getting the necessary support to prevent them reaching a crisis point and
needing NHS treatment, following 40 per cent cuts in services”.
3. The article also appeared online, in
substantially the same form, under the headline “Record 100,000 NHS admissions
for drug-related mental health treatment revealed”.
4. The complainant said that the article
was inaccurate in breach of Clause 1. He said that it was misleading to focus
on cannabis to the extent that the article did, with the headline of the print
version stating that “’[su]per skunk cannabis’ [had] led to a surge in mental
health crises” and both versions of the article reporting that “super skunk”
had “contributed” to a record number of admissions. He considered this to be
inaccurate as admissions where cannabis was referred to on a patient’s intake form
as a primary diagnosis had actually dropped between 2018/19 and 2019/20.
5. The complainant also said that the
article was inaccurate as it conflated primary and secondary diagnoses where
drug use had been noted on intake paperwork; he noted that drug use had been
referred to as a primary diagnosis in just over 7,000 cases, whereas it had
been referred to as a secondary diagnosis in over 93,000 cases. He said that
this rendered the article significantly inaccurate, as a reference to drug use
as part of secondary diagnosis does not necessarily mean that it was drug use
which led to the patient being admitted, merely that it was relevant to their
episode of care. An example the complainant provided was an individual who
suffered a broken leg and was also a regular cannabis user; in such a
hypothetical scenario, cannabis use may be referred to as a secondary diagnosis
on the intake form, even if the use had no bearing on the primary diagnosis of
a broken leg.
6. The publication said it did not accept
that the article had breached the Editors’ Code of Practice. It first said that
the article did not report that cannabis or “super skunk” had directly led to
hospital admissions; rather, the article made clear that cannabis and “super
skunk” had “contributed to a record 100,000 people admitted for NHS treatment
for drug-related mental health or behavioural disorders.” It went on to note
that where drug use is recorded as a factor in an admission – whether in a
primary or a secondary diagnosis – this indicates that it is a relevant or
contributory factor, and the article was not inaccurate for reporting the
overall admissions figure where drugs were a recorded factor. It noted that the
report itself collated these figures, under the heading “NHS hospital finished
admission episode with a primary or secondary diagnosis of drug related mental
and behavioural disorders”. The publication then said that the article wasn’t
solely based on data from NHS Digital; it also included quotations from experts
in the field, which it said – in conjunction with the data – meant that it was
accurate to extrapolate that “super skunk” had “led” and “contributed” to “a
record 100,000 people admitted for NHS treatment for drug-related mental health
or behavioural disorders.”
7. The publication went on to note that
cannabis is the most widely-used illegal recreational drug in the UK and, for
this reason, that it was entitled to focus on the contribution made by cannabis
and “super skunk” to the record figures. The publication also provided a study,
which showed that “skunk” was the most widely-available form of cannabis
available in the UK, based on police seizures. It said that such statistics
“also need to be viewed in conjunction with the conclusions of numerous
academic and scientific studies which have shown an increased risk of psychosis
and other serious mental health problems associated with smoking skunk.”
8. The complainant said that it remained
his position that the article was inaccurate in breach of Clause 1. He also
noted that the term “super skunk” had “no basis in any evidence, botany,
pharmacology, any science or any fact” and that it was “not relevant to the
hospital admissions records which include all cannabinoids”, such as those
reported on by the article. Nevertheless, the complainant said that he would be
willing to resolve his complaint on the basis that the newspaper publish a
readers’ letter from him, rebutting the inaccuracies of the article and
explaining the benefits of a legally regulated cannabis market.
9. The publication said that it would
not be content to resolve the complaint in this manner, and requested that
IPSO’s Complaints Committee make a determination as to whether the Code had
been breached.
Relevant Code Provisions
Clause 1 (Accuracy)
i) The Press must take care not to
publish inaccurate, misleading or distorted information or images, including
headlines not supported by the text.
ii) A significant inaccuracy, misleading
statement or distortion must be corrected, promptly and with due prominence,
and — where appropriate — an apology published. In cases involving IPSO, due
prominence should be as required by the regulator.
iii) A fair opportunity to reply to
significant inaccuracies should be given, when reasonably called for.
iv) The Press, while free to
editorialise and campaign, must distinguish clearly between comment, conjecture
and fact.
Findings of the Committee
10. Under the terms of the Editors’ Code of Practice, newspapers are
entitled to choose which pieces of information to publish, provided the Code is
not otherwise breached. This extends to deciding which pieces of information to
focus on. For this reason, the newspaper’s choice to focus on the contribution
of “super skunk” cannabis to NHS admissions did not, in and of itself, raise a
breach of Clause 1. However, while a newspaper is entitled to choose which
pieces of information to focus on, it must still ensure that it takes care not
to publish inaccurate, misleading, or distorted information, or headlines not supported
by the text.
11. The print headline reported that
“'Super skunk' cannabis led to surge in mental health crises”. This made a
clear causal link between “super skunk cannabis” and increased “mental health
crises” that was not supported either by the text of the article – which stated
only that the substance had “contributed” to a record number of admissions --
or the data-set upon which the article was partially based. The article did not
state that super skunk was the cause of the “record number of admissions”, and
the headline was not supported by the text of the article. The Committee also
considered that the quotes included in the article did not form a sufficient
basis for stating definitively that “super skunk” had “led” to a “surge” in
hospital admissions, where the quoted experts did not attribute the increase in
hospital admission to cannabis or “super skunk” specifically. Furthermore, the
data indicated that admissions for mental and behavioural disorders due to the
use of cannabinoids alone had fallen in the past year compared to the previous
year. The publication had not taken care not to publish inaccurate information,
and there was a breach of Clause 1 (i).
12. The published inaccuracy was
significant where the data indicated that super skunk cannabis had not led to a
surge in mental health crises, where the claim appeared prominently in the
headline, and where it misled on a matter of public health; it therefore
required correction under the terms of Clause 1 (ii). The publication had not
offered to publish any corrective action; as such there was a further breach of
Clause 1 (ii).
13. The Committee turned next to the
question of whether the article had breached Clause 1 by conflating primary and
secondary diagnoses where drug use had been noted on intake paperwork. The
Committee noted first that it was the responsibility of the publication to
accurately report on data from NHS Digital; it was not responsible for the
accuracy of the data itself. To this
end, the Committee examined the original data on which the article was based,
and noted that – while it did distinguish between primary and secondary
diagnoses of drug use – the data report itself collated these figures, and the
collated figures were included in the report under the heading “NHS hospital
finished admission episode with a primary or secondary diagnosis of drug
related mental and behavioural disorders…”. Where the report itself collated
the figures and where the article was based on the data included in the report,
the Committee found that it was not inaccurate nor misleading for the article
to collate primary and secondary diagnoses of drug related mental and
behavioural disorders, and refer to them collectively as “drug-related mental
and behavioural disorders”. There was no breach of Clause 1 on this point.
Conclusions
14. The complaint was partly upheld
under Clause 1(i) and Clause 1(ii).
Remedial Action Required
15. Having upheld a breach of Clause 1,
the Committee considered what remedial action should be required. In circumstances
where the Committee establishes a breach of the Editors’ Code, it can require
the publication of a correction and/or an adjudication, the terms and placement
of which is determined by IPSO.
16. It considered that the publication
of a correction would be sufficient to put the correct position on the record,
where the article itself was not inaccurate in breach of Clause 1.
17. The Committee then considered the
placement of this correction. It noted that the breach of Clause 1 arose only
from the print headline, therefore the correction should only be required to
appear in the print edition of the newspaper. Where the original article
appeared on page 10, the Committee found that the correction should appear on
the same page, further forward, or in an established Corrections and
Clarifications column. The wording of the correction should make clear that
there is no definitive link between “super skunk” cannabis and increased NHS
hospital admissions for the 2019/20 reporting period.
Date complaint received: 30/01/2021
Date complaint concluded by IPSO:
23/07/2021
Independent Complaints Reviewer
The publication complained to the Independent Complaints Reviewer about the process followed by IPSO in handling this complaint. The Independent Complaints Reviewer decided that the process was not flawed and did not uphold the request for review.
Back to ruling listing